196 related articles for article (PubMed ID: 22745547)
1. Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line.
Cheng J; Cheng L; Chen B; Xia G; Gao C; Song H; Bao W; Guo Q; Zhang H; Wang X
Int J Nanomedicine; 2012; 7():2843-52. PubMed ID: 22745547
[TBL] [Abstract][Full Text] [Related]
2. Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells.
Cheng J; Wu W; Chen BA; Gao F; Xu W; Gao C; Ding J; Sun Y; Song H; Bao W; Sun X; Xu C; Chen W; Chen N; Liu L; Xia G; Li X; Wang X
Int J Nanomedicine; 2009; 4():209-16. PubMed ID: 19918367
[TBL] [Abstract][Full Text] [Related]
3. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells.
Chen BA; Mao PP; Cheng J; Gao F; Xia GH; Xu WL; Shen HL; Ding JH; Gao C; Sun Q; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM
Int J Nanomedicine; 2010 Aug; 5():437-44. PubMed ID: 20957165
[TBL] [Abstract][Full Text] [Related]
5. A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
Cheng J; Wang J; Chen B; Xia G; Cai X; Liu R; Ren Y; Bao W; Wang X
Int J Nanomedicine; 2011; 6():2123-31. PubMed ID: 22114476
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic Mechanism of Human Leukemia K562/A02 Cells Induced by Magnetic Ferroferric Oxide Nanoparticles Loaded with Wogonin.
Peng MX; Wang XY; Wang F; Wang L; Xu PP; Chen B
Chin Med J (Engl); 2016 Dec; 129(24):2958-2966. PubMed ID: 27958228
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X
Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514
[TBL] [Abstract][Full Text] [Related]
8. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance.
Ren Y; Zhang H; Chen B; Cheng J; Cai X; Liu R; Xia G; Wu W; Wang S; Ding J; Gao C; Wang J; Bao W; Wang L; Tian L; Song H; Wang X
Int J Nanomedicine; 2012; 7():2261-9. PubMed ID: 22619560
[TBL] [Abstract][Full Text] [Related]
10. [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by tyrosine kinase inhibitors].
Shan XY; Chen BA; Xia GH; Xu WL; Ding JH; Gao C; Sun YY; Wang J; Cheng J; Zhao G; Bao W; Song HH; Gao F; Wang F; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):90-5. PubMed ID: 20137125
[TBL] [Abstract][Full Text] [Related]
11. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells.
Wang X; Ji C; Ma D; Zhao J; Hou M; Yu H; Zang S
Leuk Lymphoma; 2007 Aug; 48(8):1600-9. PubMed ID: 17701592
[TBL] [Abstract][Full Text] [Related]
13. Sodium azulene sulfonate reverses multidrug resistance in K562/A02 cells.
Wang Z; Zhou N; Zhao J; Zhang X
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):105-110. PubMed ID: 31880526
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance in xenograft nude-mice by magnetic Fe(3)O(4) nanoparticles combined with daunorubicin and 5-bromotetrandrine.
Wu YN; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):60-4. PubMed ID: 19236748
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells.
Chen BA; Dai YY; Wang XM; Zhang RY; Xu WL; Shen HL; Gao F; Sun Q; Deng XJ; Ding JH; Gao C; Sun YY; Cheng J; Wang J; Zhao G; Chen NN
Int J Nanomedicine; 2008; 3(3):343-50. PubMed ID: 18990943
[TBL] [Abstract][Full Text] [Related]
16. [Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02].
Liang H; Zhang Y; Zhang JD; Gu J; Ma L; Wang XL; Shen WG
Zhong Xi Yi Jie He Xue Bao; 2007 Nov; 5(6):647-50. PubMed ID: 17997939
[TBL] [Abstract][Full Text] [Related]
17. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
[TBL] [Abstract][Full Text] [Related]
18. [Study of mifepristone on reversing multidrug resistance of leukemic cell line K562/A02].
Kong DX; Chen CY; Xu FY; Jia JH
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):555-9. PubMed ID: 18078134
[TBL] [Abstract][Full Text] [Related]
19. L1EPO, a novel podophyllotoxin derivative overcomes P-glycoprotein-mediated multidrug resistance in K562/A02 cell line.
Chen H; Wang J; Zhang J; Wang Y; Cao B; Bai S; Yu PF; Bi W; Xie W
Biol Pharm Bull; 2009 Apr; 32(4):609-13. PubMed ID: 19336892
[TBL] [Abstract][Full Text] [Related]
20. [Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
Han YQ; Yuan JY; Shi YJ; Zhu Y; Wu SL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):604-8. PubMed ID: 14706144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]